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Bmf upregulation through the AMP-activated protein
kinase pathway may protect the brain from
seizure-induced cell death
C Moran1,2,4, A Sanz-Rodriguez1,3,4, A Jimenez-Pacheco1,3, J Martinez-Villareal1,3, RC McKiernan1,3, EM Jimenez-Mateos1,3,
C Mooney1,3, I Woods1, JHM Prehn1,3, DC Henshall1,3 and T Engel*,1,3
Prolonged seizures (status epilepticus, SE) can cause neuronal death within brain regions such as the hippocampus. This may
contribute to impairments in cognitive functioning and trigger or exacerbate epilepsy. Seizure-induced neuronal death is
mediated, at least in part, by apoptosis-associated signaling pathways. Indeed, mice lacking certain members of the potently
proapoptotic BH3-only subfamily of Bcl-2 proteins are protected against hippocampal damage caused by status epilepticus. The
recently identified BH3-only protein Bcl-2–modifying factor (Bmf) normally interacts with the cytoskeleton, but upon certain
cellular stresses, such as loss of extracellular matrix adhesion or energy crisis, Bmf relocalizes to mitochondria, where it can
promote Bax activation and mitochondrial dysfunction. Although Bmf has been widely reported in the hematopoietic system to
exert a proapoptotic effect, no studies have been undertaken in models of neurological disorders. To examine whether Bmf is
important for seizure-induced neuronal death, we studied Bmf induction after prolonged seizures induced by intra-amygdala
kainic acid (KA) in mice, and examined the effect of Bmf-deficiency on seizures and damage caused by SE. Seizures triggered an
early (1–8 h) transcriptional activation and accumulation of Bax in the cell death-susceptible hippocampal CA3 subfield.
Bmf mRNA was biphasically upregulated beginning at 1 h after SE and returning to normal by 8 h, while again being found
elevated in the hippocampus of epileptic mice. Bmf upregulation was prevented by Compound C, an inhibitor of adenosine
monophosphate-activated protein kinase, indicating Bmf expression may be induced in response to bioenergetic stress.
Bmf-deficient mice showed normal sensitivity to the convulsant effects of KA, but, surprisingly, displayed significantly more
neuronal death in the hippocampal CA1 and CA3 subfields after SE. These are the first studies investigating Bmf in a model of
neurologic injury, and suggest that Bmf may protect neurons against seizure-induced neuronal death in vivo.
Cell Death and Disease (2013) 4, e606; doi:10.1038/cddis.2013.136; published online 25 April 2013
Subject Category: Neuroscience
Temporal lobe epilepsy (TLE) is the most common and most
drug-refractory form of epilepsy in adults. TLE is often
associated with selective neuron loss and gliosis in the
hippocampus of patients, which may be both the cause and
consequence of recurrent seizures.1,2 Recurring seizures
may contribute to progressive damage and underlie cognitive
impairments, particularly in memory function. Therefore,
preventing hippocampal sclerosis or ongoing seizure-induced
neuronal death is a potential therapeutic strategy for mitiga-
tion or prevention of epilepsy.3,4 Apoptosis, or programmed
cell death, has been shown to be responsible for a significant
component of seizure-induced neuronal loss in different
animal models of status epilepticus (SE), and these pathways
are also regulated in human TLE.3
The Bcl-2 family of proteins are critical for the intrinsic
mitochondrial apoptotic pathway and are characterized by
shared structural motives, called Bcl-2 homology (BH)
domains. They comprise anti- and pro-apoptotic members
that function co-ordinately to control caspase-dependent
and -independent cell death.5 The proapoptotic members of
the family fall into two categories. The first are themultidomain
Bax-like molecules such as Bax and Bak, which share BH 1–3
regions. Activated Bax and/or Bak promote mitochondrial
permeability, allowing the release of apoptogenic factors such
as cytochrome c, which then promotes activation of the
caspase cascade and cell death. The second group are the
BH3-only proteins, which share only the single BH3 domain in
common. BH3-only proteins operate by binding to Bcl-2-like
prosurvival proteins to initiate apoptosis by antagonizing their
function, or possibly by directly activating Bax-like multi-
domain proteins.5,6 Members of the BH3-only proteins can be
regulated through their transcriptional expression and by
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post-translational modifications.6,7 Recent studies using
knockout models of different BH3-only proteins have shown
that the loss of some of these proapoptotic proteins can not
only provide substantial neuroprotection after SE, but that this
neuroprotection can also translate into a milder emergent
epileptic phenotype.8,9 Importantly, even though all BH3-only
proteins studied to date become activated during SE, their
contribution to cell death differs from one member to the
other.3
The recently identified protein Bmf (Bcl-2–modifying factor)
is amember of the BH3-only subgroup.10 It is found expressed
in the hematopoietic system with highest levels in immature T
and B cells, as well as in mammary glands.11 The bmf gene
encodes for a 21 kDa protein10 with various splice variants
reported.12,13 Under normal conditions in the cell, Bmf is
sequestered to the actin cytoskeleton-based myosin V motor
complex through its interaction with dynein light chain 2.10
In response to stress stimuli such as detachment of adherent
cells from their substratum (anoikis) or exposure to actin
depolymerization drugs, Bmf is released to promote apopto-
sis.10 The signals that trigger the release of Bmf remain ill-
defined, but phosphorylation of Bmf within the DLC interaction
motif has been proposed as a possible mechanism.11
Transcriptional upregulation of Bmf has been reported to be
induced by transforming growth factor beta-mediated sig-
nals,14 adenosine monophosphate-activated protein kinase
(AMPK) activation,15 histone deacetylase inhibitor treat-
ment,16 c-Jun NH(2)-terminal kinase (JNK) phosphorylation17
and cell stressors that repress CAP-dependent protein
synthesis.13 Transcriptional repression has been reported
through the Erk and Akt pathway.18 Compared with Bim, the
closest related BH3-only protein, Bmf shows only limited
proapoptotic potential, binding selectively to Bcl-2, Bcl-xl and
Bcl-w, and to a lesser extent to Mcl-1.11 Direct activation
of Bax has been observed for different BH3-only protein
members, such as Bid and Bim,19 andmore recently, although
described as a weaker activator, studies suggest Bmf might
be capable of also directly activating Bax/Bak.20 Bmf seems to
be dispensable for normal embryonic development and
organogenesis.21 Bmf knockdown has been shown to provide
substantial protection against different cell stressors, such as
glucocorticoids and g irradiation,21 histone deacetylase
inhibition,16 certain types of anoikis in epithelial cells,18,21,22
arsenic trioxide-induced cell death23 and apoptosis of beta
and renal proximal tubular cells in diabetes.15,24 Studies in
different cell types from bmf-deficient mice suggested,
however, redundancy with other BH3-only proteins during
the processes of apoptosis.25,26
A functional role for Bmf in diseases of the nervous system
has not yet been explored. Here, we investigated the role of
Bmf in amouse seizuremodel, and assessed seizure-induced
neuronal death in bmf-deficient mice.
Results
Bmf is induced after SE. To investigate the role of the
BH3-only protein Bmf in seizure-induced cell death, we
triggered SE in mice via the well-characterized method
of intra-amygdala microinjection of kainic acid (KA).27 Mice
typically showed first electrographic seizure bursts
on electroencephalogram (EEG) shortly after microinjection
of KA into the basolateral amygdala. No seizure activity was
observed in vehicle-treated mice. Mice displayed typical
behavioral changes during SE, including initial immobility,
tail extension (Straub-tail) and continuing to clonus, head
bobbing and rearing and falling and occasionally tonic-clonic
seizures with the loss of posture and jumping. Mice received
systemic lorazepam 40min after KA injection to curtail
seizures, and to reduce morbidity and mortality. As reported
before,28 analysis of hippocampal pathology 72 h after SE
showed cell death was mainly restricted to the ipsilateral CA3
hippocampal subfield shown with the neuronal cell death
marker FJB (Figures 1a and b). No cell death was observed
in control vehicle-injected animals or in the contralateral
hippocampus of mice subjected to SE (Figure 1b and data
not shown).
To confirm SE activates the intrinsic mitochondrial apopto-
tic pathway, we initially studied Bax. Bax mRNA was
significantly increased in the ipsilateral cell death-susceptible
CA3 subfield, but decreased in the less damaged ipsilateral
CA1 and dentate gyrus subfields after SE (Figure 1c and
Supplementary Figures 1a and b). Total Bax protein levels
were also increased in the ipsilateral CA3 subfield (Figure 1d).
Immunohistochemistry was next used to visualize where
in the hippocampus Bax was activated. Active Bax immunor-
eactivity, detected with the epitope-specific anti-Bax 6A7
antibody, was mainly localized in the CA3 subfield of the
hippocampus and appeared as a perinuclear, often punctate
stain consistent withmitochondrial localization (Figure 1e). No
active Bax immunoreactivity was detected in the seizure-
damaged CA3 subfield of bax-deficient mice (Figure 1e).
A causal role of Bax was not pursued in the present study
because Bax / mice displayed grossly enlarged brain
volume and brain weight when compared with wt littermates
(Supplementary Figures 1c and d).
Bmf expression was increased 1 and 4h after SE and
returned to baseline at later time-points (Figure 1f). Two
commercially available Bmf antibodies tested failed to reliably
detect Bmf protein in the brain tissue, as previously
reported.18,29
Bmf induction in epileptic mice. As reported previously,28
intermittent video and EEG monitoring of mice detected the
first spontaneous (i.e. epileptic) seizures 3–5 days after SE
(Figures 2a and b). During continuous epilepsy monitoring 2
weeks after SE, mice experienced an average 3.5±5.5
seizures per day with an average behavior (Racine scale-
based) score of 3.4±0.8 (n¼ 6). All mice experienced at
least one seizure event during 3 days of recording, consistent
with previously reported data.28,30 In tissue sections from
epileptic mice 14 days after SE, the hippocampus displayed
a visible lesion within the ipsilateral CA3 subfield comprising
neuron loss and astrogliosis (Figure 2c). The contralateral
hippocampus appeared grossly normal, without any visible
changes in cell density or gliosis (data not shown).
To determine whether there was any ongoing cell death in
these chronically epileptic mice, FJB staining was performed.
No FJB-positive cells were detected in the CA3 region of the
ipsilateral hippocampus of epileptic mice 14 days after SE
(Figure 2d). Interestingly, despite no apparent ongoing
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neurodegeneration in epileptic mice, bmf mRNA was
increased 14 days after SE in ipsilateral hippocampal tissue
(Figure 2e).
Bmf induction through AMPK after SE. We next investi-
gated potential pathways regulating Bmf expression after SE.
Bmf has been shown to be induced by different kinases,
including JNK17 and AMPK.15 We previously showed
JNK pathway induction in the present model.9 Whether
AMPK is induced in our model is unknown. To explore this,
we immunoblotted with antibodies against phosphorylated
AMPK, which is a read-out of increased AMPK function.31
AMPK phosphorylation increased shortly after SE in mice
(Figures 3a and b). To test whether specific inhibitors
for these pathways repress bmf expression after SE, mice
were given an intracerebroventricular (i.c.v.) injection of
either SP600125 (25 mM) (reversible inhibitor of JNK) or
Compound C (1mM) (reversible inhibitor of AMPK) before
intra-amygdala KA injection. All vehicle-, SP600125- and
Compound C- treated mice developed SE after KA injection,
and seizure durations recorded by surface EEG were not
significantly different between groups (data not shown and
Figures 3c and d). Cortical EEG recordings are an accurate
indicator of intra-hippocampal seizure activity in this model.9
Figure 1 Bmf induction after SE. (a) Representative photomicrograph of a coronal brain section at the level of the dorsal ipsilateral hippocampus 72 h after SE showing
FJB-positive cells mainly in the CA3 subfield (arrows), whereas CA1 and dentate gyrus (DG) are mainly spared from cell death. (b) Average number of FJB-positive cells at a
single level of the dorsal ipsilateral CA3 hippocampal subfield 72 h after SE (n¼ 5 per group; ***Po0.001). No cell death was observed in control (Con) non-seizure mice.
(c) Graph showing increased bax mRNA in cell death-susceptible ipsilateral CA3, 8 h after SE (n¼ 4 per group; *Po0.05) when compared with ipsilateral CA3 from control
(Con) mice. (d) Representative western blots (n¼ 1 per lane) of cell lysates from ipsilateral CA3 subfield showing increased levels of Bax after SE when compared with
ipsilateral CA3 from control (Con) mice. a-Tubulin is shown as a loading control. (e) Confocal immunofluorescence photomicrographs showing cells positive for active Bax 8 h
after SE in the CA3 region of the hippocampus. Note, no specific staining was present in the CA3 subfield of bax-deficient mice 8 h after SE (bottom right panel) and in control
(Con) wt mice. (f) Graph showing increased bmf mRNA levels after SE (n¼ 7 (vehicle, control (Con)) and 5 (mice after SE)) when compared with control mice. CA¼ cornus
ammonis. Scale bar, 250mm (a) and 50mm (e)
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Analysis of EEG included standard measures of seizure
activity, such as scoring of high-amplitude high-frequency
discharges (HAHFDs) and automated analysis of EEG
power.30,32 As before, bmf mRNA was significantly upregu-
lated after SE in vehicle-injected mice when compared with
non-seizure control mice (Figure 3e). In contrast, bmf mRNA
was not increased in mice pretreated with the specific AMPK
inhibitor Compound C (Figure 3e). No differences in
hippocampal bmf mRNA levels were found between non-
KA vehicle- and Compound C-injected control mice (data not
shown). No difference in bmf upregulation was found
between seizure-vehicle mice and mice treated with the
specific JNK inhibitor (data not shown). These results
suggest that bmf mRNA is induced after SE at least in part
by the cell stress sensor AMPK.
We also examined cell death in mice treated with
Compound C compared with vehicle-injected seizure
controls. Mice pretreated with the specific AMPK inhibitor
Compound C displayed increased seizure-induced cell death
compared with vehicle-injected SE mice (Figures 3f and g).
We note that hippocampal damage levels in vehicle-injected
mice in this part of the study are slightly lower than in the
normal model, perhaps due to effects of vehicle (DMSO) on
neuronal death.33
Hippocampal morphology, glutamate receptor expres-
sion and response to KA in Bmf-deficient mice. To
determine whether Bmf is required for seizure-induced
neuronal death in the hippocampus, we compared wild-type
(Bmfþ /þ ) and Bmf-deficient (Bmf / ) mice in this
model. To examine whether Bmf / mice display any
developmental abnormalities that might render them more
or less prone to seizures or hippocampal damage, we
examined neuron numbers and KA receptor expression in
the hippocampus. No gross hippocampal abnormalities were
present in Bmf  / mouse brains (Figures 4a and b) and
Figure 2 Bmf induction in mice with epilepsy. (a) Representative EEG recording of a spontaneous seizure and, (b) video stills showing typical tonic-clonic behavior during
an epileptic seizure detected 14 days after SE. (c) Representative photomicrographs showing reactive astrocytes (GFAP, green) and loss of NeuN-positive neurons (red) in
the ipsilateral CA3 subfield in epileptic mice 14 days after SE. Note, decreased neuronal density in ipsilateral CA3 (white arrows). (d) Representative photomicrograph of FJB-
stained coronal brain section at the level of the dorsal ipsilateral hippocampus of an epileptic mouse 14 days after SE. No ongoing neurodegeneration is present. (e) Graph
showing increased bmf mRNA levels in epileptic mice 14 days post SE when compared with control (Con) mice (n¼ 8 (Con) and 5 (14 days post SE). **Po0.01 compared
with control. Scale bar, 100mm (c) and 250mm (d)
Bmf in seizure-induced cell death
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counts of NeuN-stained hippocampal subfields from
Bmfþ /þ and Bmf  / mice revealed similar numbers of
neurons in the CA1 and CA3 hippocampal subfield (Figures
4a and b). Western blotting revealed no difference between
genotypes for protein levels of the KA receptors GluR6/7 and
KA2 (Figures 4c and d and data not shown). As expected,
no expression of bmf mRNA was detected in Bmf  / mice
(Figure 4e).
To establish whether or not Bmf  / mice underwent an
episode of SE equivalent to wt mice, animals from both
groups were equipped with skull-mounted electrodes, and we
recorded and quantified EEG between the time of KA
microinjection and administration of lorazepam. No difference
was found betweenBmfþ /þ andBmf / mice in total seizure
time, total seizure power, amplitude and frequency (Figures
4f–j). Behavioral analysis confirmed EEG recordings showing
no differences between Bmf þ /þ and Bmf  / mice during
first 40min after KA injection using amodified Racine scale for
mice. All mice injected with KA developed SE with no
differences in severity between genotypes (n¼ 5 per group;
P¼ 0.91). To ensure that seizure cessation was the same
between genotypes, EEG was recorded for an additional hour
after lorazepam administration. No difference could be
observed in seizure total power between genotypes in post
lorazepam monitored EEG (Figures 4k and l).
Moreover, no difference between genotypes was observed
in the expression of the activity-regulated cytoskeleton-
associated protein (Arc), an immediate early gene whose
expression is a marker of increased neuronal activity34
(data not shown). To rule out any compensatory effects of
other BH3-only proteins on SE-induced cell death in Bmf  /
mice, real-time qPCR was performed for bim and puma, both
of which have been implicated in seizure-induced cell death
before.8,9 No significant difference in the expresssion of
bim and puma mRNA was found after SE between Bmf þ /þ
and Bmf  / mice (data not shown).
Increased vulnerability to seizure-induced neuronal
death in Bmf-deficient mice. Last, we examined the
histopathological consequences of SE in Bmf / mice.
To assess hippocampal damage, FJB staining was
performed 72h after SE. As expected, Bmfþ /þ mice
displayed damage that was mainly located in the ipsilateral
CA3 subfield of the hippocampus, with almost no cell death
Figure 3 Upregulation of bmf after SE is blocked by AMPK inhibition. (a) Representative western blots (n¼ 1 per lane) showing increased AMPK phosphorylation
(AMPK-P) 1 h after SE. No changes in total AMPK levels after SE were found. a-Tubulin is shown as a loading control. (b) Graph showing increased AMPK phosphorylation 1 h
after SE (n¼ 4 per group). (c) Graphs showing similar total seizure power during 40 min recoding period of cortical EEG starting after KA injection until injection of lorazepam in
mice injected with Compound C (Comp C) compared with vehicle-injected (Veh) mice. (d) Representative seizure spectrogram showing amplitude and frequency during SE in
mice treated with vehicle and Comp C. (e) Graph showing increased bmf mRNA levels 4 h after SE in vehicle-treated mice when compared with non-seizure control (Con)
mice, whereas no bmf mRNA increase was found in SE mice pretreated with the AMPK inhibitor Comp C (n¼ 7 (Con) and 4 (Comp C)). (f) Graph showing increased cell death
in Comp C-treated mice when compared with vehicle-injected mice 24 h after SE (n¼ 5 per group). (g) Representative photomicrographs of the CA3 subfield 24 h after SE of
vehicle- and Comp C-treated mice. Scale bar in g, 50mm; *Po0.05 when compared with control
Bmf in seizure-induced cell death
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visible in the hilus and CA1 region (Figures 5a and b).
In contrast, Bmf / mice showed significantly more hippo-
campal damage when compared with Bmfþ /þ littermates
(Figures 5a and b). Cell death was not only increased in the
cell death-susceptible CA3 region (Figures 5c and d), but
was also increased in the normally cell death-resistant
subfield CA1 (Figures 5e and f). FJB-positive cells were also
frequently present in the hilus and the contralateral hippo-
campus in Bmf  / mice (Figures 5g and h).
We previously reported neuroprotection during SE to exert
an anti-epileptogenic effect in our model.8,35 To explore
whether bmf-deficiency and the resulting increase in cell
death has an impact on the emergent epileptic phenotype,
Bmfþ /þ and Bmf / mice were video recorded continuously
for 5 consecutive days 14 days after SE. Bmf / mice
experienced B30% more spontaneous seizures when
compared with Bmfþ /þ mice (Supplementary Table 1).
Discussion
In the present study, we report for the first time that the
BH3-only protein Bmf is upregulated after SE and in epilepsy.
Figure 4 Normal hippocampal morphology and response to intra-amygdala KA in Bmf / mice. Graph and representative photomicrographs showing similar numbers of
NeuN-positive cells in the CA3 (a) and CA1 (b) subfield of Bmf þ /þ and Bmf  / mice (n¼ 3 per group). (c) Representative western blot (n¼ 1 per lane) and corresponding
graph (d) showing similar levels of the KA receptor subtype 6 (Glu6/7) between Bmf þ /þ and Bmf  / mice. b-Actin is shown as loading control (n¼ 3 per group). (e) Real-
time qPCR analysis confirming absence of bmf mRNA was detected in Bmf  / mice (n¼ 4 per group). (f) Graph and representative EEG traces showing similar amount of
HAHFDs during SE induced by intra-amygdala KA between Bmf þ /þ and Bmf  / mice recorded by Grass Comet digital EEG (n¼ 10 per group). (g–i) Graphs showing
similar total power, amplitude and frequency between Bmf þ /þ and Bmf  / mice during SE (n¼ 10 per group). (j) Representative seizure spectrogram showing amplitude
and frequency during SE in Bmf þ /þ and Bmf  / mice. (k) Graph and (l) representative seizure spectrogram showing amplitude and frequency for 1 h following lorazepam
injection in Bmf þ /þ and Bmf  / mice. ***Po0.001 when compared with Bmf þ /þ . Scale bar in a, 100mm
Bmf in seizure-induced cell death
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This was blocked by an inhibitor of AMPK implying thismay be
driven by seizure-induced ATP depletion. Critically, and in
contrast to the established proapoptotic function of Bmf in
non-neuronal tissue, we show that seizure-induced neuronal
death is increased in the absence of the bmf gene. These are
the first studies to explore Bmf regulation in a model of
neurological disease, and suggest Bmf may be required
to protect the brain against the harmful effects of seizures.
BH3-only proteins have emerged as novel regulators of
seizure-induced cell death.3 Among the BH3-only proteins
profiled to date, activation of several occurs in the hippocam-
pus after SE, but only Puma and Bim appear to be causally
involved in cell death. The most neuroprotection was
observed when Puma was deleted.8,36 Loss of Bim resulted
in protection in one study9, but failed to protect in another
KA model37, and Bid knockout mice showed similar damage
as wild typemice after SE.38 This underscores the importance
of elucidating the functional contribution of novel BH3-only
proteins with the most pronounced effects.3 Here, we
examined the novel BH3-only protein Bmf. A strength of the
present study is that we have used the same SE model as
was employed in the work on Puma, Bim and Bid, ensuring we
can directly compare results to previous findings. The present
study showed that SE results in increased expression of bmf
in the hippocampus, expanding further the list of BH3-only
proteins activated by seizures. This also increases the already
considerable experimental and human evidence that seizures
activate apoptosis-associated pathways in the brain.
Induction of bmf was rapid following seizures, in the same
timeframe as Bax activation in the CA3 subfield at mitochon-
dria. Whether Bax is required for seizure-induced neuronal
death could not be established, because of the abnormalities
of Bax / brains. Studying the functional role of Bax during
SE will likely require conditional deletion of bax, to exclude
effects on seizures or results being obscured by differences in
cell densities. Regardless, these data are consistent with Bmf
fulfilling an apical role in the signaling pathways induced by SE
in the mouse hippocampus.
Figure 5 Increased vulnerability to seizure-induced neuronal death in Bmf / mice. (a) Graph and (b) representative field view photomicrograph showing more
FJB-positive cells in the ipsilateral hippocampus 72 h after SE in Bmf  / mice when compared with Bmf þ /þ mice (n¼ 10 per group). Arrows mark areas of cell death.
(c–f) Graph and representative photomicrographs showing increased FJB-positive cells in ipsilateral hippocampal subfields CA3 and CA1 in Bmf  / mice when compared
with Bmf þ /þ mice (n¼ 10 per group). (g and h) Photomicrographs showing presence of increased cell death in ipsilateral hilus (P¼ 0.18) and contralateral hippocampus
(P¼ 0.18) 72 h after SE (n¼ 10). *Po0.05 when compared with Bmf þ /þ . Scale bar, 250mm (b, h) and 150mm (d, f and g)
Bmf in seizure-induced cell death
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A number of pathways have been identified that control
BH3-only protein induction after SE, including p53,8 Foxo,39
JNK9 and caspases.40 Bmf upregulation has previously been
reported after various stimuli, including anoikis, UV radiation
and AMPK activation.11 Here, we found that the AMPK
inhibitor Compound C prevented bmf upregulation after SE,
whereas a JNK inhibitor had no effect, suggesting bmf gene
expression is mainly regulated through the AMPK pathway.
This is consistent with a recently identified mechanism of Bmf
induction in non-neuronal cells.15 AMPK inhibition did not
decrease basal levels of bmf expression, suggesting other
transcription factors being responsible to maintain normal
physiological bmf levels. Another potential mechanism of
AMPK activation, through CaMKK,41 is unlikely as seizures
are known to decrease function of this enzyme.42 This is the
first BH3-only protein to be linked to an energy-sensing
pathway in the setting of seizures. Seizure activity can lead to
energy depletion in affected brain regions.43,44 This results in
activation of the bioenergetic cell stress sensor AMPK45,46,
which suppresses key enzymes involved in ATP-consuming
anabolic pathways and increases cellular ATP supply.47
Interestingly, activation of AMPK and BH3-only proteins has
both been linked to the induction of autophagy,6,48 which has
been reported to be protective during seizure-induced cell
death.49 However, protein levels of autophagy-regulated
proteins did not differ between Bmfþ /þ and Bmf / mice
after SE (TE, unpublished data). We cannot rule out that
other, possibly post-translational modifications occur to Bmf.
Indeed, previous work has shown Bmf to undergo phosphor-
ylation by JNK,17 an enzyme activated by seizures in the
present model.9 Other Bmf isoforms also exist, which have
been reported to have different functions.12,13
Bmf was induced both acutely, after SE, and also in
experimental epilepsy. This was unlikely to be due to active
neurodegeneration, which is largely undetectable by 14 days
post SE (presented data and28). Rather, spontaneous
seizures may trigger bmf levels to increase in the mouse
hippocampus. We do not know which of the hippocampal
subfields contributes to bmf induction during chronic epilepsy.
It may be the damaged CA3 subfield, which is only partly
lesioned by SE and which has been shown to be the source of
spontaneous seizure generation in this model,50 but contribu-
tions from other subfields are also possible. These are the first
data to look at BH3-only protein induction in epileptic mice in
this model, and suggest that both spontaneous and induced
seizures upregulate the expression of Bmf.
The second major finding in the present study was that,
unexpectedly, seizure-induced neuronal death was increased
in mice lacking bmf. This increase was not restricted to the
ipsilateral CA3 subfield alone, with increased damage
extending into the CA1 also, an area normally relatively
resistant to cell death in this model.28 We also saw a trend to
increased damage in the hilus and in the contralateral side of
the bmf-deficient mouse hippocampus. Surface EEG record-
ings suggested mice underwent similar seizures. The present
data implies, therefore, that Bmf protects the hippocampus
against seizure-induced neuronal death in vivo. Our Com-
pound C data are also consistent with a protective role of
BMF, as Compound C blocked the expression of bmf and
increased seizure-induced cell death. The present finding of
higher spontaneous seizure frequency inBmf / mice is also
consistent with previous findings in this model, where larger
CA3 lesions were associated with more frequent epileptic
seizures.51 These data contrast with previous studies of BH3-
only proteins in the same model that showed proapoptotic or
redundant roles.3 Thus, Bmf represents the first BH3-only
protein to be shown to have an anti-apoptotic function during
seizure-induced neuronal death in vivo.
The present study is the first to examine seizure-induced
neuronal death in vivo in mice lacking one of the weaker BH3-
only proteins. Bim, Puma or Bid are essential to activate the
mitochondrial apoptotic pathway, but the weaker BH3-only
proteins are now thought not essential to promote apopto-
sis.52 The results of the present study suggest Bmf not only
does not promote apoptosis after seizures but, instead,
serves an anti-apoptotic role. Bmf does not, therefore,
perform the same functions in the brain that have been
ascribed in other tissues.10,11 The brain is largely postmitotic,
and proteins may well be co-opted to serve other functions
which, when lost, disrupt neurophysiology and increase
vulnerability to cell death. Although this is the first BH3-only
protein to be assigned an anti-apoptotic role in the brain, loss
of Bak, an otherwise proapoptotic protein, also increased
seizure-induced neuronal death.53 Non-apoptotic roles have
also been described for other Bcl-2 proteins in the brain, with
Bad and Bax implicated in synaptic plasticity, including long-
term depression.53,54 Bmf-deficient animals showed the same
response to intra-amygdala KA, suggesting that Bmf probably
does not influence basal neurotransmission or excitability of
neurons. One possible limitation of the present work is the use
of cortical EEG, but previous work shows that there is a strong
correlation between cortical seizures with hippocampal
seizures and damage in our model.9,55 Elucidating the
constitutive function of Bmf in the brain may provide insight
into why loss of Bmf enhances injury after prolonged seizures.
It is tempting to speculate a link exists with cell energy, and
other BH3-only proteins have been linked to cell metabo-
lism.56 Indeed, a recent study has shown that AMPK inhibition
can lead to increased cell death by downregulating target
genes that normally downregulate oxidative stress.46
In conclusion, the present study demonstrates that
prolonged and single seizures in vivo activate the BH3-only
protein Bmf. Induction of Bmf, at least following SE, may involve
the AMPK pathway. Contrary to expectations, Bmf-deficiency
increased seizure-induced neuronal death, suggesting Bmfmay
protect against the harmful effects of prolonged or repeated
seizures in vivo. These data further demonstrate the functional
influence of some Bcl-2 family proteins during seizure-induced
neuronal death and importantly, to potentially novel roles for
BH3-only proteins that may influence future approaches to
neuroprotection and, possibly, anti-epileptogenesis.
Materials and Methods
Animal seizure model. All animal procedures were performed in
accordance with the principles of the European Communities Council Directive
(86/609/EEC) and the National Institutes of Health’s Guide for the Care and Use of
Laboratory Animals. Procedures were reviewed and approved by the Research
Ethics Committee of the Royal College of Surgeons in Ireland, under license from
the Department of Health, Dublin, Ireland. Studies were performed according
to previously described techniques.57 Adult male mice (20–25 g) (C57BL/6
(Harlan, UK), Bmfþ /þ and Bmf / (10) and Baxþ /þ and Bax / mice
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(Jackson Laboratory, Bar Harbor, ME, USA (strain B6.129 1-Baxtm1Sjk/J))
underwent seizures induced by unilateral sterotaxic microinjection of KA Ocean
Produce International (Shelburne, NS, Canada) into the basolateral amygdala
nucleus. Briefly, mice were anesthetized using isoflurane (3–5%) and maintained
normothermic by means of a feedback-controlled heat blanket (Harvard Apparatus
Ltd, Kent, England). Next, mice were placed in a stereotaxic frame and following a
midline scalp incision, three partial craniotomies were performed. Mice were
affixed with three skull-mounted recording electrodes (Bilaney Consultants Ltd,
Sevenoaks, Kent, UK) to record surface EEG. Electrodes were placed above the
dorsal hippocampus and a third over the frontal cortex. EEG was recorded using a
Grass Comet digital EEG (Medivent Ltd, Lucan, Ireland). A guide cannula was
affixed over the dura (co-ordinates from Bregma: A P¼  0.94; L¼  2.85 mm)
and the entire skull assembly fixed in place with dental cement. Anesthesia was
discontinued, EEG recordings were commenced, and then a 31-gauge internal
cannula (Plastic One Inc., Roanoke, VI, USA) was inserted into the lumen of the
guide to inject KA (0.3mg in 0.2ml of vehicle; phosphate-buffered saline (PBS), pH
adjusted to 7.4) into the amygdala. Non-seizure control animals received the same
volume of intra-amygdala vehicle. EEG was recorded until intra-peritoneal
lorazepam (6 mg/kg) administration at 40 min. Mice were euthanized after 1, 4, 8,
24, 72 h and 14 days after anticonvulsant, and brains were microdissected on ice
and processed for protein analysis, as described below, or flash-frozen whole in 2-
methylbutane at  30 1C for immunohistochemistry as previously described.57
Brains from additional naı¨ve (non-instrumented) Bmf þ /þ and Bmf  / mice were
used to examine hippocampal neuroanatomy and basal gene expression. To
examine the brain abnormalities in Bax  / mice, male Bax þ /þ and Bax  /
mice of same age were saline perfused, extracted and weighed on a scale.
Quantification of EEG. Digitized EEG recordings were analyzed off-line using
manual assessment and automated software as described.57 The duration of high-
frequency (45 Hz) and high-amplitude (42X baseline) polyspike discharges of
Z5 s duration (HAHFDs), which are synonymous with injury-causing electrographic
activity, was counted by a reviewer blind to the treatment. Further EEG analysis was
performed by uploading EEG into Labchart7 software (ADInstruments, Oxford, UK) to
calculate total power, amplitude and frequency of the EEG signal.
Analysis of spontaneous seizures using EEG telemetry. Long-
term EEG recording to define the emergence of epilepsy in wild-type mice was
performed using implantable EEG telemetry units (Data Sciences International
(DSI), St. Paul, MN, USA), as described previously.32 Mice underwent the same
initial surgical procedure for affixing the injection cannula, but were equipped with
EEG transmitters (F20-EET, DSI) to record bilateral EEG from skull screws
overlying the dorsal ipsilateral and contralateral hippocampi. EEG data were
acquired using the Dataquest A.R.T. system (DSI). Following surgery, mice
received intra-amygdala KA, and then telemetry units were activated. Epileptic
seizures were defined as high-frequency (45 Hz) high-amplitude (42
baseline) polyspike discharges of Z5 s duration.
Analysis of behavioral changes during SE and spontaneous
seizures by continuous video monitoring. Bmfþ /þ and Bmf /
mice were subjected to intra-amygdala KA-induced SE as described above, and
epileptic seizure frequency determined as previously published.30 Mice were either
monitored during 40 min after KA injection or allowed to recover after SE, and were
then housed in pairs in clear Perspex cages. Webcam-style cameras connected to
laptop computers were placed 40 cm from the cages in a room equipped with safe
lights for night-time recordings. Images were captured using VirtualDub 1.9.11
(SourceForge.net) with a sampling rate of 10 frames per second and a data transfer
rate of 140 kb/s. Videos from first 40 min after KA injection until lorazepam treatment
or from 5 days of continuous monitoring were reviewed by an observer unaware of
the experimental treatment. Seizures were counted using a modified six-point
Racine scale for mice. The scores were determined as follows: (1) immobility and
sudden freezing; (2) forelimb and or tail extension, rigid posture; (3) repetitive
movements, head bobbing; (4) rearing and falling; (5) continuous rearing and falling;
or (6) severe tonic-clonic seizures. For spontaneous seizure scoring clinical events
scoring below 2 such as sudden freezing and immobility were not included.
Compound C and JNK inhibitor treatment. Mice received a 2ml i.c.v.
injection of the JNK inhibitor SP600125 (25mM) in DMSO9 4 h before intra-amygdala
KA. Vehicle mice received DMSO alone. For AMPK inhibition, mice received a 2ml
i.c.v. injection of Compound C (1 mM) in DMSO 4 h before SE.
Western blotting. Western blotting was performed as previously described.38
Whole hippocampi or CA3 subfields were homogenized in lysis buffer and protein
concentration was determined. Fifty microgram protein samples were boiled in gel-
loading buffer and separated on 10 to 15% SDS-PAGE gels. Proteins were
transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) and then
incubated with antibodies against the following: Full-length Bax (Upstate
Biotechnologies, Millipore Ireland BV, Cork, Ireland), AMPK and AMPK-P (Cell
Signaling Technology, Danvers, MA, USA), Glu6/7 (Chemicon, Hampshire, UK),
KA2 (Merck Millipore, Cork, Ireland), BMF (N-terminal from Prosci, Poway, CA,
USA; internal region of BMF protein, Santa Cruz, Germany, Heidelberg), b-Actin
(Sigma-Aldrich, Dublin, Ireland) and a-Tubulin (Santa Cruz Biotechnology,
Heidelberg, Germany). Membranes were then incubated with horseradish
peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch, Ply-
mouth, PA, USA) and bands visualized using Supersignal West Pico
Chemiluminescent Substrate (Pierce, Rockford, IL, USA). Images were captured
using a Fuji-film LAS-300, densitometry performed using AlphaEaseFC4.0
software, and data expressed as change relative to control.
RNA extraction and real time-quantitative PCR. RNA extraction was
undertaken as previously described using Trizol (Invitrogen).35 Briefly, one
microgram total RNA was used to generate cDNA by reverse transcription using
Superscript II Reverse Transcriptase enzyme (Invitrogen, Dublin, Ireland).
Quantitative real-time PCR was performed using a LightCycler 1.5 (Roche
Diagnostics, Sussex, UK) in combination with QuantiTech SYBR Green PCR kit
(Qiagen Ltd, Crawley, UK) as per manufacturer’s protocol and 1.25mM of primer
pair used. Data were analyzed by LightCycler 1.5 software, data normalized to
expression of b-actin and represented at RQ values. Primers were designed using
Primer3 software (http://frodo.wi.mit.edu) and verified by BLAST (http://blas-
t.ncbi.nlm.nih.gov/Blast.cgi). Primers sequences: Arc: forward-50-TGACTCA-
CAACTGCCACACA3-30, reverse-50-ATGAGGAAGCCAGATCGTGT-30; Puma:
forward-50-TCTCAGGAAAGGCTGCTGGT-30, reverse-50-GCTGGGCACTGGGT-




Confocal microscopy. For confocal microscopy, animals were transcar-
dially perfused with 4% PFA, brains were removed and post-fixed for 1 day, and
then cut on a vibratome (INTRACEL, Royston, UK) in 30 mm thick sections.
Sections were washed in PBS and permeabilized with 0.2% CHAPS/PBS for
5 min. Following permeabilization, slides were blocked for 1 h in PBS/1% bovine
serum albumin/3% serum. Bax conformational change was detected with the anti-
Bax 6A7. Primary antibody was diluted 1:500 in blocking buffer and was added
and incubated overnight at 4 1C. Sections were washed three times with PBS, and
incubated with a 1:250 dilution of FITC-conjugated goat anti-mouse secondary
antibody (Jackson Immuno Research Europe, Suffolk, UK) for 2 h at room
temperature. Next, sections were incubated for 10 min with DAPI at RT, washed in
PBS and coverslipped with Fluorosave. Confocal images were acquired with a
Leica TCR 6500 microscope equipped with four laser lines (405, 488, 561 and
653 nm) using a 63X immersion oil objective (NA 1.3).
Histopathology. Fresh-frozen coronal brain sections at the level of the
dorsal hippocampus were air-dried, fixed in formalin and stained with antibodies
against NeuN (Chemicon, Hampshire, UK) and detected by goat anti-mouse
AlexaFluor 568 (Bio Sciences, Dublin, Ireland). Neuronal damage was assessed
by Fluoro-Jade B staining (FJB) (Millipore, Cork, Ireland).57 Sections were
imaged using a Nikon 2000s epifluorescence microscope with a Hamamatsu
Orca 285 camera (Micron-Optical, Wexford, Ireland). Semi-quantification of
damaged and/or surviving cells was performed for the entire CA3 subfield,
beginning at the border with CA2 through to the end of CA3c/CA4 within the
hilus of the dentate gyrus and for the entire CA1 subfield beginning at border
with CA2 through to the end of CA1. Counts were the average of two adjacent
sections assessed by an observer masked to experimental group/condition.
For investigation of the brain architecture in wild-type and Bmf / mice, naive
brains were also prepared. Sections were prepared and immunostained for
NeuN.
Data analysis. Data are presented as means±S.E. Data were analyzed
using ANOVA with post-hoc Fisher’s PLSD test, Student’s t-test for two-group
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comparison and Mann–Whitney test for non-parametric data (StatView software;
SAS Institute, Cary, NC, USA). Significance was accepted at Po0.05.
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